2549 results found
The first 5 years of a child’s life are a critical time period for influencing growth, development and learning.1
In providing a safe and healthy workplace, we provide an environment in which we can all effectively contribute to achieving community and business outcomes.
MRFF – Preventive and Public Health Research Initiative – 2024 Enhancing Medical Device Surveillance Through Registries Grant Opportunity
Additional guidance on what constitutes a Probity Event under the NHMRC Funding Agreement.
We are committed to setting high standards in ethics in health care and research.
Leukaemias are difficult-to-treat blood cancers, which are common among both young and older people. In Australia in 2023, around 20,000 people were diagnosed with a blood cancer and blood cancers accounted for an estimated 38% of all cancer cases among the 0–19 year-old age group. Over 5,000 Australians die each year from blood cancers.1 NHMRC-funded researchers at WEHI have made revolutionary breakthroughs in our understanding of leukaemia biology, leading to the development of a new type of anti-cancer drug, venetoclax, that has significantly improved treatment for leukaemia patients.
Otitis media (OM) is a common and complex disease of childhood and refers to inflammation and/or infection of the middle ear. Aboriginal and Torres Strait Islander children have an increased risk of developing OM compared to their non-Aboriginal or Torres Strait Islander counterparts. 1,2,3
Fetal Alcohol Spectrum Disorder (FASD) is caused by prenatal alcohol exposure and is characterised by severe neurodevelopmental impairment, that may include intellectual disability, behavioural and other developmental problems.1,2 FASD causes a significant burden to individuals, the health care, education, and justice systems and society.1,2
Despite improvements in vaccine uptake in Aboriginal and Torres Strait Islander people, adults experience greater rates of influenza hospitalisation than non-Indigenous adults of the same age.
Eleven Australian health and medical researchers will receive a share in over $45 million to undertake ground-breaking collaborative research through the National Health and Medical Research Council (NHMRC) Partnership Project scheme.
The objective of the CTCS Grant scheme is to support high-quality clinical trials and cohort studies that address important gaps in knowledge, leading to relevant and implementable findings for the benefit of human health.
Australia’s capacity for health and medical research translation is receiving a $3.7 million funding boost to help improve public health policy and service delivery.
Knowledge gained through research underpins improvements in Australia's health and medical services. This research can be fundamental or can be applied, directly addressing clinical problems, public policy, quality of life and environmental health issues or the provision of health services.
National Science Week is an annual celebration that promotes and encourages interest in STEMM and acknowledges the contributions of Australian scientists to our ever-growing world of knowledge.In this Speaking of Science webinar held during National Science Week (10 August – 18 August 2024), we were joined by the inspirational cell biologist and Laboratory Head at WEHI and the University of Melbourne, Professor Shalin Naik. Professor Naik is well versed in communicating complex science concepts across to the public in more simple ways where possible, and without belittling the important work that underlies it. In this webinar, he did just that!
Chikungunya is a mosquito-transmitted viral disease characterised by sporadic, unpredictable outbreaks. Due to international travel and the spread of potential disease-carrying vectors such as mosquitos, chikungunya virus (CHIKV) infections have been identified in over 125 countries.1 Over the past 20 years, more than 10 million chikungunya virus infections have been reported, highlighting CHIKV as a significant global health threat. An international consortium involving NHMRC-funded researchers at Griffith University has developed 2 vaccines against CHIKV.
NHMRC, guided by its Principal Committee Indigenous Caucus (PCIC), conducted a national consultation on the Indigenous Research Excellence Criteria (IREC) to consider how the criteria are working in practice and whether improvements are needed.
As a recommended action under NHMRC’s Road Map 3: A strategic framework for improving Aboriginal and Torres Strait Islander health through research and associated Action Plan 2021–2024 Triennium, a review of the Indigenous Research Excellence Criteria (IREC) was undertaken in 2023. This included national consultation with the feedback considered by the Principal Committee Indigenous Caucus (PCIC) and a consultation report released in December 2023.A key finding from the Review, which was endorsed by PCIC, is that there is strong support for adoption of an approach where all NHMRC applications need to answer a question about how the proposed research will benefit Aboriginal and/or Torres Strait Islander health. This is aligned with the National Agreement on Closing the Gap, which aims to enable Aboriginal and Torres Strait Islander people and governments to work together to overcome the inequality experienced by Aboriginal and Torres Strait Islander people, and achieve life outcomes equal to all Australians.